Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Passive immunotherapy for Alzheimer's disease: challenges & future directions

Yi LX, Tan EK, Zhou ZD.

J Transl Med. 2024 May 7;22(1):430. doi: 10.1186/s12967-024-05248-x.

CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment

Tripathi S, Sharma Y, Rane R, Kumar D.

CNS Neurol Disord Drug Targets. 2024;23(12):1405-1424. doi: 10.2174/0118715273283786240408034408.

Estrogen signalling and Alzheimer's disease: Decoding molecular mechanisms for therapeutic breakthrough

Rishabh, Rohilla M, Bansal S, Bansal N, Chauhan S, Sharma S, Goyal N, Gupta S.

Eur J Neurosci. 2024 Jul;60(1):3466-3490. doi: 10.1111/ejn.16360. Epub 2024 May 10.

PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease

Kumar M, Sharma AA, Datusalia AK, Khatik GL.

Med Chem. 2024;20(8):781-798. doi: 10.2174/0115734064295063240422100615.

From aberrant neurodevelopment to neurodegeneration: Insights into the hub gene associated with autism and alzheimer's disease

Fu Y, Xie GM, Liu RQ, Xie JL, Zhang J, Zhang J.

Brain Res. 2024 Sep 1;1838:148992. doi: 10.1016/j.brainres.2024.148992. Epub 2024 May 8.

Updated safety results from phase 3 lecanemab study in early Alzheimer's disease

Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M, Kanekiyo M, Li D, Purcell D, Dhadda S, Irizarry M, Kramer L.

Alzheimers Res Ther. 2024 May 10;16(1):105. doi: 10.1186/s13195-024-01441-8.

Chronic Traumatic Encephalopathy as the Course of Alzheimer's Disease

Pszczołowska M, Walczak K, Miśków W, Antosz K, Batko J, Kurpas D, Leszek J.

Int J Mol Sci. 2024 Apr 24;25(9):4639. doi: 10.3390/ijms25094639.

Role of Calcitriol and Vitamin D Receptor (VDR) Gene Polymorphisms in Alzheimer's Disease

Jeong SP, Sharma N, An SSA.

Int J Mol Sci. 2024 Apr 28;25(9):4806. doi: 10.3390/ijms25094806.

Targeting excitatory:inhibitory network imbalance in Alzheimer's disease

Blum D, Levi S.

Brain. 2024 Jun 3;147(6):1931-1933. doi: 10.1093/brain/awae146.

Natural Antioxidants: An Effective Strategy for the Treatment of Alzheimer's Disease at the Early Stage

Wang Y, Huang Y, Ma A, You J, Miao J, Li J.

J Agric Food Chem. 2024 May 29;72(21):11854-11870. doi: 10.1021/acs.jafc.4c01323. Epub 2024 May 14.

The impact of chelating compounds on Cu(2+), Fe(2+)/(3+), and Zn(2+) ions in Alzheimer's disease treatment

Mazur T, Malik M, Bieńko DC.

J Inorg Biochem. 2024 Aug;257:112601. doi: 10.1016/j.jinorgbio.2024.112601. Epub 2024 May 9.

Editorial - FAU research on Alzheimer's disease

Fields GB.

J Cell Physiol. 2024 Jun;239(6):e31316. doi: 10.1002/jcp.31316. Epub 2024 May 15.

The vascular contribution of apolipoprotein E to Alzheimer's disease

Chen F, Zhao J, Meng F, He F, Ni J, Fu Y.

Brain. 2024 Sep 3;147(9):2946-2965. doi: 10.1093/brain/awae156.

Short-chain fatty acids: Important components of the gut-brain axis against AD

Huang Y, Wang YF, Miao J, Zheng RF, Li JY.

Biomed Pharmacother. 2024 Jun;175:116601. doi: 10.1016/j.biopha.2024.116601. Epub 2024 May 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias